Will Wallis

Let’s Think helps people think brilliantly. We’re future proofing the professions, starting with legal services. Our pioneering Behavioural Science AI technology decodes the complex thought processes that drive strategic insights and decision making – providing the scaffolding to transform workplace productivity software beyond automation tools that think for you to science-led technology that helps you think. With Behavioural Science AI at its core, the Let’s Think® Knowledge Exchange is our SaaS-based practical knowledge elicitation, reflection and expertise sharing platform that enables law firms to catalogue, safeguard and monetise the unique intellectual capital that drives their success. The Knowledge Exchange makes expertise accessible firmwide, preserves valuable IP when seniors leave or retire, and scales mentorship and training for juniors – accelerating their growth and billability. As an accredited B Corp, our ethos is to do business in a way that benefits people, communities, and the planet. If you’d like to learn more about how Behavioural Science AI can help to future proof your law firm, get in touch at hello@letsthink.com.

Green Eight Capital is a mission-driven private markets investment firm that seeks to deliver superior uncorrelated returns while capitalizing generation-defining innovations and shaping a better future. We invest in global aerospace and adjacent industries where we see a confluence of megatrends and actionable opportunity. Our approach grounds industry thought leadership with disciplined investment process and portfolio construction to provide differentiated returns tied to foundational technologies, businesses, and leaders.

EDX Medical Group PLC develops innovative digital diagnostic products and services, enabling personalised treatment for cancer, heart disease and infectious diseases. The company is listed on the Access Segment of the AQSE Growth Market (TIDM: EDX). EDX Medical was founded by Professor Sir Christopher Evans, OBE, a medical and life sciences entrepreneur with more than 30 years of experience, together with CEO, Dr Mike Hudson. By translating clinical insights into pragmatic solutions combining advanced biological and digital technologies, EDX Medical seeks to cost-effectively improve the detection and characterisation of disease in order to personalise treatment in a timely fashion. Early disease detection and biologically-based personal treatment optimisation is considered to be the most impactful way of reducing deaths and lowering the cost of healthcare globally. EDX Medical Group operates a molecular biology and diagnostics laboratory in Cambridge, UK, and 100%-owned subsidiary companies, Hutano Diagnostics Limited in Oxford, UK, and Torax Biosciences Ltd in Ireland. EDX Medical provides testing and genomic sequencing services, undertakes quality assurance, conducts research & development (R&D) and has established expertise in the design, development, validation and sourcing of diagnostic testing solutions to ISO 13485. Key laboratory tests performed by the Company have been accredited to ISO 15189 by the United Kingdom Accreditation Service (UKAS).

ProtonDx is revolutionising the world of rapid, molecular testing at point of need. Our goal is to ensure specific viral detection diagnosis uncertainty is a thing of the past. Our expertise is in cutting edge electronics, molecular biology, and machine learning which we have blended together to create novel portable connected devices. Powered by highly sensitive LAMP technology, these are providing new robust methods to identify multiple pathogens, quickly and accurately. This approach puts us at the forefront in the global fight against antimicrobial resistance. Spun out of Imperial College London in March 2020, ProtonDx ambition is to ensure tests can be conducted quickly, accurately and cost effectively, wherever and whenever they are needed throughout the world so that all can benefit from advances in technology. Our innovative lab on a chip technology has already received many awards including the 2020 IEEE CASS COVID 19 Entrepreneur’s award, the IEEE Sensors Technical Achievement award, IET Mike Sergeant Achievement Medal, Rosetrees Trust Interdisciplinary Prize, Wellcome Trust Innovator Award, two Imperial Techcelerate Awards, MedTech SuperConnector Award, and various other IEEE awards.

Disciple is where communities thrive. Our community management platform helps people build independent, valuable and trusted communities in a safe space that they own and control. Create your own unique social space today.

Glint is reintroducing gold as money. Buy, save, spend and send any amount of gold (and other currencies) instantly at the best rates. Download our free app today and get your Glint Mastercard.

Silverbullet is the leading Boutique Customer Experience (CX) Partner, designed to support enterprise organisations in the delivery of transformative marketing customer journeys across multiple touch-points. In essence, we help our clients to better communicate with their customers, whilst maximising their investment in data and technology. Today, Silverbullet specialises in delivering smart customer journey orchestration services on behalf of global clients. Through our tried and tested ‘four steps to success’, we enable businesses to curate their CX strategy and utilise the right marketing technology, in order to activate across a variety of digital marketing channels (including owned and paid). https://linktr.ee/wearesilverbullet

Hofmeister Brewing Company was relaunched in 2017 by co-founders and friends, Richard Longhurst and Spencer Chambers. Now British owned and proudly independent, its signature beer, Hofmeister Helles, is an authentic imported Bavarian lager that’s slow brewed and cold fermented in the heart of Bavaria. Hofmeister Helles is made according to the ancient Reinheitsgebot German beer purity law by a fourth generation family brewery who are one of only four certified slow brewers in this historical brewing region. Using only three local ingredients; pure mineral water, locally grown barley and Hallertau Hops, Hofmeister beer is laagered slower at zero degrees for a fresh, crisp, Helles lager with an ABV of 5%. Hofmeister Helles is internationally awarded and the current holder of IWSC World’s Best Lager and double gold at the European Beer Challenge. Ingredients, process, and integrity has helped to foster a rapidly growing presence across independent high-end pubs, bars, hotels and restaurants who demand a premium lager offering, including Harrods and the Connaught Hotel.

With over 30 years experience in the development of devices in the medical and cosmetic market the Cosmeditech team are excited to introduce the new range of aesthetic & cosmetic systems. With state of the art design and based on many years of clinical research, the new Cosmeditech range brings the latest innovation in non surgical aesthetic treatments. Cosmeditech is the UK’s leading developer and manufacturer of advanced light and laser technology systems for use in medical and cosmetic procedures. Applying ground-breaking innovations in the laser industry to respond to the dermatological and cosmetic challenges facing medical professionals.

At Touchlight we are revolutionising DNA. Our Company and technology is built on the conviction that DNA is fundamental to the future of medicine. By moving away from todays restrictive biological approaches, we have made DNA simple. Our unique dbDNA™ (or "doggybone" DNA) vector is optimised for use in advanced genetic medicines, being safer and more efficacious than conventional plasmid DNA. The platform, based on enzymatic technology, enable DNA production at unprecedented scale, speed and purity. We are leveraging our platform to develop the next generation of DNA vaccines for oncology and infectious diseases, in house and in collaboration with industry partners and academics, as well as enabling manufacture of advanced therapies (viral vectors, mRNA vaccines, and cell therapies) through our CDMO, Touchlight DNA Services. For more information please visit our website or get in touch by emailing info@touchlight.com.

Money Mover's multi-currency account allows you to receive, hold, convert and pay in over 25 currencies and provides everything you need to operate your business internationally. We’ve designed it from the ground up to take the hassle out of foreign exchange and international money transfer. We’re helping our users save money on each transaction and provide a transparent, seamless experience throughout the entire process. Our service is provided in a safe and regulated environment that protects personal information and ensures secure payment.

Let’s Think helps people think brilliantly. We’re future proofing the professions, starting with legal services. Our pioneering Behavioural Science AI technology decodes the complex thought processes that drive strategic insights and decision making – providing the scaffolding to transform workplace productivity software beyond automation tools that think for you to science-led technology that helps you think. With Behavioural Science AI at its core, the Let’s Think® Knowledge Exchange is our SaaS-based practical knowledge elicitation, reflection and expertise sharing platform that enables law firms to catalogue, safeguard and monetise the unique intellectual capital that drives their success. The Knowledge Exchange makes expertise accessible firmwide, preserves valuable IP when seniors leave or retire, and scales mentorship and training for juniors – accelerating their growth and billability. As an accredited B Corp, our ethos is to do business in a way that benefits people, communities, and the planet. If you’d like to learn more about how Behavioural Science AI can help to future proof your law firm, get in touch at hello@letsthink.com.

Green Eight Capital is a mission-driven private markets investment firm that seeks to deliver superior uncorrelated returns while capitalizing generation-defining innovations and shaping a better future. We invest in global aerospace and adjacent industries where we see a confluence of megatrends and actionable opportunity. Our approach grounds industry thought leadership with disciplined investment process and portfolio construction to provide differentiated returns tied to foundational technologies, businesses, and leaders.

Our Investment strategy is driven by the principles of supporting established companies in traditional sectors and adding value by implementing digital process for efficiency and growth for a new generation.

EDX Medical Group PLC develops innovative digital diagnostic products and services, enabling personalised treatment for cancer, heart disease and infectious diseases. The company is listed on the Access Segment of the AQSE Growth Market (TIDM: EDX). EDX Medical was founded by Professor Sir Christopher Evans, OBE, a medical and life sciences entrepreneur with more than 30 years of experience, together with CEO, Dr Mike Hudson. By translating clinical insights into pragmatic solutions combining advanced biological and digital technologies, EDX Medical seeks to cost-effectively improve the detection and characterisation of disease in order to personalise treatment in a timely fashion. Early disease detection and biologically-based personal treatment optimisation is considered to be the most impactful way of reducing deaths and lowering the cost of healthcare globally. EDX Medical Group operates a molecular biology and diagnostics laboratory in Cambridge, UK, and 100%-owned subsidiary companies, Hutano Diagnostics Limited in Oxford, UK, and Torax Biosciences Ltd in Ireland. EDX Medical provides testing and genomic sequencing services, undertakes quality assurance, conducts research & development (R&D) and has established expertise in the design, development, validation and sourcing of diagnostic testing solutions to ISO 13485. Key laboratory tests performed by the Company have been accredited to ISO 15189 by the United Kingdom Accreditation Service (UKAS).

ProtonDx is revolutionising the world of rapid, molecular testing at point of need. Our goal is to ensure specific viral detection diagnosis uncertainty is a thing of the past. Our expertise is in cutting edge electronics, molecular biology, and machine learning which we have blended together to create novel portable connected devices. Powered by highly sensitive LAMP technology, these are providing new robust methods to identify multiple pathogens, quickly and accurately. This approach puts us at the forefront in the global fight against antimicrobial resistance. Spun out of Imperial College London in March 2020, ProtonDx ambition is to ensure tests can be conducted quickly, accurately and cost effectively, wherever and whenever they are needed throughout the world so that all can benefit from advances in technology. Our innovative lab on a chip technology has already received many awards including the 2020 IEEE CASS COVID 19 Entrepreneur’s award, the IEEE Sensors Technical Achievement award, IET Mike Sergeant Achievement Medal, Rosetrees Trust Interdisciplinary Prize, Wellcome Trust Innovator Award, two Imperial Techcelerate Awards, MedTech SuperConnector Award, and various other IEEE awards.